ACM
Advent Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 200 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 207 |
|
|
2021
Q1 | – | Sell |
-4,520
| Closed | -$396K | – | 249 |
|
|
2020
Q4 | $396K | Buy |
4,520
+520
| +13% | +$45.6K | 0.01% | 165 |
|
|
2020
Q3 | $304K | Buy |
+4,000
| New | +$304K | 0.01% | 162 |
|
|
2018
Q4 | – | Sell |
-8,600
| Closed | -$834K | – | 220 |
|
|
2018
Q3 | $834K | Buy |
+8,600
| New | +$834K | 0.02% | 187 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 241 |
|
|
2017
Q3 | – | Sell |
-5,500
| Closed | -$500K | – | 250 |
|
|
2017
Q2 | $500K | Buy |
5,500
+2,860
| +108% | +$260K | 0.01% | 206 |
|
|
2017
Q1 | $232K | Buy |
+2,640
| New | +$232K | ﹤0.01% | 207 |
|
|
2016
Q4 | – | Sell |
-3,450
| Closed | -$319K | – | 237 |
|
|
2016
Q3 | $319K | Buy |
+3,450
| New | +$319K | ﹤0.01% | 404 |
|
|
2016
Q2 | – | Sell |
-4,000
| Closed | -$330K | – | 404 |
|
|
2016
Q1 | $330K | Buy |
4,000
+1,047
| +35% | +$86.4K | 0.01% | 339 |
|
|
2015
Q4 | $313K | Sell |
2,953
-1,704
| -37% | -$181K | ﹤0.01% | 368 |
|
|
2015
Q3 | $490K | Buy |
4,657
+4,055
| +674% | +$427K | 0.01% | 400 |
|
|
2015
Q2 | $82K | Sell |
602
-52,488
| -99% | -$7.15M | ﹤0.01% | 437 |
|
|
2015
Q1 | $6.62M | Buy |
53,090
+44,490
| +517% | +$5.54M | 0.1% | 210 |
|
|
2014
Q4 | $777K | Sell |
8,600
-14,746
| -63% | -$1.33M | 0.01% | 389 |
|
|
2014
Q3 | $1.69M | Sell |
23,346
-355
| -1% | -$25.6K | 0.03% | 352 |
|
|
2014
Q2 | $1.66M | Buy |
+23,701
| New | +$1.66M | 0.02% | 350 |
|
|
2013
Q4 | – | Sell |
-41,261
| Closed | -$2.98M | – | 601 |
|
|
2013
Q3 | $2.98M | Buy |
41,261
+4,261
| +12% | +$308K | 0.04% | 339 |
|
|
2013
Q2 | $2.06M | Buy |
+37,000
| New | +$2.06M | 0.03% | 343 |
|